You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):41項醫療器械產品取得CE認證證書
格隆匯 09-23 15:45

格隆匯 9 月 23日丨迪瑞醫療(300396.SZ)公佈,公司41項醫療器械產品於近取得了CE認證證書。

次取得的產品涉及IVD行業中化學發光免疫分析,生化診斷分析及質譜技術等。化學發光免疫分析應用涵蓋多個病種,包括腫瘤、甲功、激素、傳染病、心肌標誌物等。生化診斷是最早實現自動化的檢測手段,目前醫療衞生機構是消費生化試劑產品的主力軍。質譜技術具有不依賴抗體既能區別眾多分子間微小的分子量差異的優勢在臨牀中有着不可替代的應用潛力。

公司始終注重自主研發和技術創新,在儀器及試劑方面陸續推出新品產品進入收穫期,公司產品出口120個國家國際市場營業收入呈現增長狀態,經十餘年培育以優越的產品質量,以其超強的性價比已經形成了良好的國際口碑,公司將繼續開發補充臨牀高價值檢驗項目,持續豐富體外診斷產品覆蓋領域。

上述產品取得CE認證證書,表明產品符合歐盟相關要求,已經具備歐盟市場的准入條件,將進一步增強公司產品的綜合競爭力,對公司未來的經營將產生積極影響。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測對公司未來業績的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account